Frederique Ph.D. Menzaghi - Dec 17, 2021 Form 4 Insider Report for Cara Therapeutics, Inc. (CARA)

Role
Chief Scientific Off,SVP-R&D
Signature
/s/Darren DeStefano, Attorney-in-Fact
Stock symbol
CARA
Transactions as of
Dec 17, 2021
Transactions value $
$0
Form type
4
Date filed
12/21/2021, 04:32 PM
Previous filing
Sep 1, 2021
Next filing
Mar 1, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CARA Common Stock Award $0 +12.6K +8.94% $0.00 154K Dec 17, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares underlying restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents the contingent right to receive one share of common stock of the Issuer. The RSUs vest as to (i) 50% on December 15, 2022; and (ii) 50% on June 15, 2023, subject to the Reporting Person's continued service with the Issuer through each such vesting date.